Reprint
Pharmacogenomics
From Basic Research to Clinical Implementation
Edited by
March 2022
162 pages
- ISBN978-3-0365-2835-9 (Hardback)
- ISBN978-3-0365-2834-2 (PDF)
This is a Reprint of the Special Issue Pharmacogenomics: From Basic Research to Clinical Implementation that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
pharmacogenomics; return of results; genetic counseling; qualitative; pharmacogenetics; pharmacogenomics; implementation; pharmacogenetics service; pharmacogenetics; pharmacogenomics; implementation; screening; pre-emptive; personalized medicine; precision medicine; community pharmacy; pharmacogenomic testing; pharmacogenetics; genetic privacy; pharmaco-economics; polymorphisms; pharmacogenes; pharmacogenomic; machine learning; adaptation; human evolution; pharmacogenomics; precision medicine; US Food and Drug Administration; clinical actionability; pharmacogenomics; clinical translation; chronic kidney disease; CYP3A5; polymorphism; progression; pharmacogenomics (PGx); pediatrics; best practice alerts (BPAs); electronic health records (EHR); genomic indicators; clinical decision support (CDS); phenotype; genotype; pharmacogenomics; polypharmacy; chronic disease; medication management; electronic medical record; artificial intelligence; n/a